Renova Therapeutics to present key components of FLOURISH gene therapy trial for the treatment of heart failure at … – PR Newswire (press release)
|
Renova Therapeutics to present key components of FLOURISH gene therapy trial for the treatment of heart failure at …
PR Newswire (press release) Renova Therapeutics is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. The first indications the company is犀利士5mg pursuing are gene therapy treatments for heart … |
